Loading ...

Fast insight into nanotechnology

Access easily searchable nanoscience data, synthesis methods and literature

doxorubicin/poly((2-(dimethylamino)ethyl methacrylate)-co-(diacetone acrylamide))-alginic acid complex nanoparticles conjugate

Based on

1 Articles
2013 Most recent source

Composition

Image only illustrates the order and placement of components as described in literature.

1

poly((2-(dimethylamino)ethyl methacrylate)-co-(diacetone acrylamide))

poly(DEMA-co-DAA)
Type Polymer
Formula
Role core
2

doxorubicin

adriblastin adriamycin DOX DXR
Type Single Compound
Formula C27H29NO11
Role layer
3

alginic acid

alginate algin
Type Biomolecule
Formula
Role layer

Properties

General physical and chemical properties

Property Value Nanomaterial Variant Source
drug embedding rate

More information/entries available to subscribers only.

Or, view sample content

Applications

Area Application Nanomaterial Variant Source
drug delivery

More information available to subscribers only.

Or, view sample content

Characterization

Biological effects

Preparation

Method 1

Type: Chemical synthesis
Source:
Starting materials
  • alginic acid
  • doxorubicin
  • 2-(N,N-dimethylamino) ethyl methacrylate
See all (4)
  1. AVWROcitYC6JNbhfa
  2. iGM5S0pquSPvEonrFlZCvb5wh9qVL472hJ3uKpTRQENhJYcgHcywlACydX64COsJD0FIQB
Product

doxorubicin/poly((2-(dimethylamino)ethyl methacrylate)-co-(diacetone acrylamide))-alginic acid complex nanoparticles conjugate

Size: not specified

Medium/Support: none

Method 2

Type: Chemical synthesis
Source:
Starting materials
  • alginic acid
  • diacetone acrylamide
  • 2-(N,N-dimethylamino) ethyl methacrylate
See all (4)
  1. 5T4Xt2AdWdl6eTSyt
  2. DVPhGd1lOxzcAb25UymjqnFFjDcxJP9rndUNFYXWlaBnN2rf0Pffzrc3dmvaajMW7HlSvv
Product

doxorubicin/poly((2-(dimethylamino)ethyl methacrylate)-co-(diacetone acrylamide))-alginic acid complex nanoparticles conjugate

Size: not specified

Medium/Support: none

Method 3

Type: Chemical synthesis
Source:
Starting materials
  • alginic acid
  • doxorubicin
  • diacetone acrylamide
See all (4)
  1. KOZrS0KUnRea1ljBY
  2. GzfCtSotHuaPgWMQIpyDlnHUeNUsBm7H1Q9KcE07TApLWlMmxJkYz6FaeByRui7W6ccOoB
Product

doxorubicin/poly((2-(dimethylamino)ethyl methacrylate)-co-(diacetone acrylamide))-alginic acid complex nanoparticles conjugate

Size: not specified

Medium/Support: none

Method 4

Type: Chemical synthesis
Source:
Starting materials
  • alginic acid
  • 2-(N,N-dimethylamino) ethyl methacrylate
  • diacetone acrylamide
See all (4)
  1. lyraJg52HkcPMwxja
  2. Q6TwGCpBTebFJPlXB3yGsLvDFvMWGPETN9Q2XXeFB4pleoQ36Uqpo7jdtBnLJuTercA59f
Product

doxorubicin/poly((2-(dimethylamino)ethyl methacrylate)-co-(diacetone acrylamide))-alginic acid complex nanoparticles conjugate

Size: not specified

Medium/Support: none

References

Full content is available to subscribers only

To view content please choose from the following:

We use cookies to improve your experience with our site. More information

Sign up for a free trial